Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Characterization and outcomes in patients with mogamulizumab-associated skin reactions in the MAVORIC trial. European journal of cancer (Oxford, England : 1990) Musiek, A. C., Whittaker, S., Horowitz, S. M., Bagot, M., Huen, A., Fisher, D. C., Haun, P., Vermeer, M. H., Ito, T., Dwyer, K., Herr, F., Kim, Y. H. 2021; 156 Suppl 1: S46
View details for DOI 10.1016/S0959-8049(21)00712-7
View details for PubMedID 34649656